ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.75
+0.03 (0.34%)
At close: Jun 26, 2026, 4:00 PM EDT
8.73
-0.02 (-0.23%)
After-hours: Jun 26, 2026, 7:59 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$788,043
Profits / Employee
$255,570
Market Cap
2.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Kardigan | 241 |
| Precigen | 160 |
| Taysha Gene Therapies | 99 |
| Rapport Therapeutics | 84 |
ADMA News
- 2 days ago - ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 3 days ago - Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders - Newsfile Corp
- 11 days ago - 20 growth stocks priced as value stocks - Market Watch
- 15 days ago - $ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law - Business Wire
- 16 days ago - Adma Biologics resumed with an Outperform at Raymond James - TheFly
- 16 days ago - ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 23 days ago - ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation - GlobeNewsWire
- 24 days ago - ADMA Biologics Transcript: AGM 2026 - Transcripts